Makita et al.
4.22-4.20 (m, 4H), 4.11-4.08 (m, 4H), 3.91 (s, 3H), 3.77-3.72
(m, 8H), 3.59-3.56 (m, 4H), 3.33-3.27 (m, 6H), 2.97 (s, 2H),
2.35 (s, 6H), 0.86 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 167.0,
166.7, 147.7, 143.5, 138.3, 137.9, 135.0, 131.7, 131.1, 129.9, 129.7,
129.5, 128.4, 127.9, 127.4, 127.3, 121.9, 112.9, 77.6, 72.6, 71.0,
70.4, 68.4, 65.9, 58.0, 53.8, 52.2, 34.7, 22.1, 21.3; mp 149-150
°C; HRMS (FAB-MS) calcd for C55H70NO13 952.4842 ([M -
3.70-3.60 (m, 8H), 3.23-3.12 (m, 8H), 2.85-2.80 (m, 4H), 2.20,
2.19 (two s, 6H), 0.93-0.94 (m, 6H); 13C NMR (125 MHz, CDCl3)
δ 167.1, 148.6, 137.9, 131.0, 129.8, 129.2, 129.0, 128.3, 127.1,
126.5, 120.6, 111.6, 72.7, 69.7, 69.4, 69.3, 68.0, 66.8, 52.2, 38.1,
24.0, 23.8, 20.9; mp 48-50 °C; HRMS (FAB-MS) calcd for
C58H70Cl3NO15 1125.3811 ([M]+), found 1125.3822 ([M]+). Anal.
Calcd for C58H70Cl3NO15: C, 61.78; H, 6.26; N, 1.24. Found: C,
61.42; H, 6.06; N, 1.42.
PF6]+), found 952.4856 [M
-
PF6]+. Anal. Calcd for
N-Acylated rotaxane (4cr): 1H NMR (500 MHz, CDCl3) δ 8.20
(d, 2H, J ) 8.3 Hz), 8.11 (s, 2H), 7.98 (d, 2H, J ) 8.3 Hz), 7.33
(d, 2H, J ) 8.3 Hz), 7.10 (s, 1H), 6.88-6.81 (m, 8H), 5.97 (s,
2H), 4.52 (s, 2H), 4.51 (s, 1H), 4.09-4.01 (m, 4H), 3.89 (s, 3H),
3.71-3.68 (m, 4H), 3.61-3.58 (m, 4H), 3.42-3.21 (m, 4H), 3.17
(s, 2H), 3.16 (s, 2H), 2.84-2.81 (m, 4H), 2.22 (s, 6H), 0.94 (s,
6H); 13C NMR (125 MHz, CDCl3) δ 168.7, 168.6, 167.4, 148.6,
148.6, 145.6, 138.7, 138.3, 137.9, 137.7, 134.4, 130.9, 129.5, 129.5,
129.3, 129.2, 129.1, 128.6, 128.5, 126.5, 126.1, 125.6, 124.2, 120,7,
120.5, 113.0, 111.6, 111.4, 106.4, 69.8, 69.6, 69.4, 68.1, 67.6, 50.9,
47.8, 29.9, 24.5, 21.7, 21.5, 21.4, 21.0; mp 126-127 °C; HRMS
(FAB-MS) calcd for C57H68F3NO14 1047.4592 ([M]+), found
1047.4606 ([M]+).
C55H70F6NO13P: C, 60.16; H, 6.43; N, 1.28. Found: C, 59.96; H,
6.23; N, 1.26.
General Procedure for the Neutralization-Induced Dethread-
ing of Rotaxane. A solution of rotaxane (5.4 µmol) and triethy-
lamine (7.0 µL, 54 µmol) in CD3CN (0.60 mL) was allowed to
stand at 60 °C. The progress of the dethreading was monitored by
1H NMR.
General Procedure for N-Acylation. A solution of rotaxane
(5.4 µmol), acylation reagent (0.54 mmol), triethylamine (7.0 µL,
54 µmol), and DMAP (0.7 mg, 0.54 µmol) in CD3CN (0.60 mL)
was allowed to stand at room temperature for 0.5 h. After water
was added, the mixture was extracted by chloroform. The organic
layer was dried over magnesium sulfate and evaporated in vacuo.
The crude product was purified by preparative gel permeation
chromatography (chloroform) to afford N-acylated rotaxane and the
dethreading product.
Rotaxane (7)13: 1H NMR (500 MHz, CDCl3) δ 7.56 (brs, 2H),
7.35 (d, 2H, J ) 8.3 Hz), 7.20 (d, 2H, J ) 8.3 Hz), 6.91-6.88 (m,
4H), 6.84 (s, 1H), 6.81-6.79 (m, 4H), 5.01 (s, 2H), 4.66-4.63
(m, 2H), 4.46-4.44 (m, 2H), 4.11-4.10 (m, 8H), 3.78-3.77 (m,
8H), 3.63 (s, 3H), 3.50-3.43 (m, 8H), 2.49 (s, 2H), 2.42 (s, 2H),
1.10 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 172.4, 171.7, 147.6,
138.5, 137.5, 131.7, 131.5, 130.8, 129.7, 128.2, 126.8, 121.8, 112.8,
70.8, 70.3, 68.3, 65.3, 52.8, 52.4, 51.4, 45.1, 32.8, 27.7, 21.3; mp
48-49 °C; HRMS (ESI-TOF) calcd for C49H66NO12 860.4580 ([M
- PF6]+), found 860.4561 [M - PF6]+. Anal. Calcd for
C49H66F6NO12P: C, 58.50; H, 6.61; N, 1.39. Found: C, 58.50; H,
6.94; N, 1.55.
1
N-Acylated rotaxane (4bp): H NMR (500 MHz, CDCl3) δ
8.16-8.11 (m, 4H), 7.09 (s, 1H), 7.00-6.94 (m, 2H), 6.89-6.81
(m, 8H), 5.98 (two s, 2H), 4.66, 4.37 (two s, 2H), 4.10-4.03 (m,
8H), 3.73-3.71 (m, 4H), 3.64-3.62 (m, 4H), 3.27-3.23 (m, 4H),
2.96-2.85 (m, 6H), 2.21 (s, 6H), 1.51, 1.49 (two s, 9H), 0.92, 0.89
(two s, 9H); 13C NMR (125 MHz, CDCl3) δ 167.2, 148.6, 137.8,
134.2, 129.4, 129.3, 128.4, 127.3, 126.6, 125.1, 120.6, 111.6, 84.5,
69.7, 69.5, 69.4, 68.0, 66.9, 57.4, 53.4, 52.7, 34.3, 33.8, 28.5, 28.4,
27.7, 21.0; mp 96-98 °C; ESI-MS m/z 910.10 [M + Na]+. Anal.
Calcd for C51H69NO12: C, 68.97; H, 7.83; N, 1.58. Found: C, 68.68;
H, 7.58; N, 1.45.
N-Acylated rotaxane (8): 1H NMR (500 MHz, CD3CN, 333K)
δ 7.87 (d, 2H, J ) 7.8 Hz), 7.41-7.37 (m, 6H), 6.93-6.87 (m,
10H,), 6.76 (brs, 2H), 5.66 (s, 2H), 4.38 (brs, 4H), 4.13-4.03 (m,
8H), 3.69-3.63 (m, 8H), 3.53 (s, 3H), 3.39-3.34 (m, 4H), 3.07
(brs, 4H), 2.41 (s, 2H), 2.30 (s, 2H), 2.25 (s, 6H), 0.89 (brs, 6H).
Decomposition of Rotaxane (8).14 A solution of rotaxane 8 (5.4
µmol) in CD3CN (0.60 mL) was allowed to stand at 333 K. The
N-Acylated rotaxane (4cp): 1H NMR (500 MHz, CDCl3) δ 8.15,
8.14 (two s, 2H), 8.10 (brs s, 2H), 8.00-7.98 (m, 2H), 7.35-7.33
(m, 2H), 7.07 (m, 2H), 7.03-6.94 (m, 2H), 6.86-6.79 (m, 8H),
4.54, 4.44 (two s, 2H), 4.42, 4.33 (two s, 2H), 4.08-4.01 (m, 8H),
3.90, 3.89 (two s, 2H), 3.72-3.60 (m, 8H), 3.27-3.23 (m, 4H),
3.17, 3.04 (two s, 2H), 3.13, 3.11 (two s, 2H), 2.90-2.86 (m, 4H),
2.20 (s, 6H), 1.48, 1.48 (two s, 9H), 0.95, 0.91 (two s, 9H); 13C
NMR (125 MHz, CDCl3) δ 167.2, 167.1, 148.6, 137.7, 134.2, 134.0,
131.0, 129.8, 129.5, 129.4, 128.4, 127.2, 127.2, 127.1, 126.4, 120.6,
111.6, 84.6, 72.7, 72.6, 69.7, 69.5, 69.4, 68.0, 66.9, 53.8, 53.1, 53.0,
52.4, 52.2, 38.1, 37.7, 29.9, 27.7, 23.8, 23.7, 21.0; mp 58-59 °C;
HRMS (FAB-MS) calcd for C60H77NNaO15 1074.5185 ([M +
Na]+), found 1074.5145 ([M + Na]+).
1
progress of the dethreading was monitored by H NMR.
Acknowledgment. This work was funded by the Sasakawa
Scientific Research Grant from The Japan Science Society.
Supporting Information Available: Experimental details,
spectroscopic and analytical data for new compounds, and X-ray
crystallographic files (CIF) for rotaxane 1b and 4cr. This
material is available free of charge via the Internet at
1
N-Acylated rotaxane (4cq): H NMR (500 MHz, CDCl3) δ
8.19-8.16 (m, 2H), 8.11-8.08 (m, 2H), 8.00-7.98 (m, 2H),
7.38-7.33 (m, 2H), 7.09-7.07 (m, 1H), 7.03-6.98 (m, 2H),
6.89-6.80 (m, 8H), 5.97, 5.96 (two s, 2H), 4.69, 4.54 (two s, 2H),
4.50-4.40 (m, 4H), 4.10-4.01 (m, 8H), 3.90, 3.88 (two s, 3H),
JO8013726
9250 J. Org. Chem. Vol. 73, No. 23, 2008